220 related articles for article (PubMed ID: 15026557)
1. Cytochrome P450 enzymes: novel options for cancer therapeutics.
McFadyen MC; Melvin WT; Murray GI
Mol Cancer Ther; 2004 Mar; 3(3):363-71. PubMed ID: 15026557
[TBL] [Abstract][Full Text] [Related]
2. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific expression of cytochrome P450 CYP1B1.
Murray GI; Taylor MC; McFadyen MC; McKay JA; Greenlee WF; Burke MD; Melvin WT
Cancer Res; 1997 Jul; 57(14):3026-31. PubMed ID: 9230218
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Ciolino HP; MacDonald CJ; Yeh GC
Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.
McFadyen MC; McLeod HL; Jackson FC; Melvin WT; Doehmer J; Murray GI
Biochem Pharmacol; 2001 Jul; 62(2):207-12. PubMed ID: 11389879
[TBL] [Abstract][Full Text] [Related]
6. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.
Bruno RD; Njar VC
Bioorg Med Chem; 2007 Aug; 15(15):5047-60. PubMed ID: 17544277
[TBL] [Abstract][Full Text] [Related]
7. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
van Schaik RH
Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1B1: a novel anticancer therapeutic target.
McFadyen MC; Murray GI
Future Oncol; 2005 Apr; 1(2):259-63. PubMed ID: 16555997
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome p450 for cancer prevention and therapy.
Chen TC
Anticancer Agents Med Chem; 2014 Jan; 14(1):52-3. PubMed ID: 23869784
[No Abstract] [Full Text] [Related]
10. The role of cytochrome P450 in tumour development and progression and its potential in therapy.
Murray GI
J Pathol; 2000 Dec; 192(4):419-26. PubMed ID: 11113857
[TBL] [Abstract][Full Text] [Related]
11. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.
Rochat B
Clin Pharmacokinet; 2005; 44(4):349-66. PubMed ID: 15828850
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.
Sharma R; Gatchie L; Williams IS; Jain SK; Vishwakarma RA; Chaudhuri B; Bharate SB
Bioorg Med Chem Lett; 2017 Dec; 27(24):5400-5403. PubMed ID: 29150398
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450s in the development of target-based anticancer drugs.
Purnapatre K; Khattar SK; Saini KS
Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
[TBL] [Abstract][Full Text] [Related]
14. Cancer pharmacogenomics: achievements in basic research.
Nakajima M; Yokoi T
Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
[TBL] [Abstract][Full Text] [Related]
15. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
16. The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions.
Rooney PH; Telfer C; McFadyen MC; Melvin WT; Murray GI
Curr Cancer Drug Targets; 2004 May; 4(3):257-65. PubMed ID: 15134533
[TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy.
Njar VC
Mini Rev Med Chem; 2002 Jun; 2(3):261-9. PubMed ID: 12370067
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytochromes p450: existing and new promising therapeutic targets.
Schuster I; Bernhardt R
Drug Metab Rev; 2007; 39(2-3):481-99. PubMed ID: 17786634
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytochrome P450 in tumor tissues and its association with cancer development.
Oyama T; Kagawa N; Kunugita N; Kitagawa K; Ogawa M; Yamaguchi T; Suzuki R; Kinaga T; Yashima Y; Ozaki S; Isse T; Kim YD; Kim H; Kawamoto T
Front Biosci; 2004 May; 9():1967-76. PubMed ID: 14977602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
